Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $95.65 | $23.50 | 307.09% | 207.93x | 160.30x | 12.99x | 16.09x | 1.48x | $119.79M | 1.20% | $637.99M | 6.11 | $10.17B | -1,481.08 | ||
| LQDA | LIQUIDIA CORP | $80.89 | $17.16 | 371.49% | 337.04x | 24.35x | 24.71x | 66.25x | 1.66x | $41.15M | 0.58% | $108.58M | 1.23 | $7.15B | 133.51 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $271.37 | $92.42 | 193.62% | 62.24x | 36.12x | 8.41x | 33.69x | 1.27x | $641.34M | 1.78% | $1.08B | 8.09 | $37.49B | 40.55 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.78 | $2.75 | 219.80% | 125.43x | 78.25x | 4.76x | 116.50x | 1.20x | $47.52M | 3.18% | $13.01M | 0.08 | $1.66B | 31.12 | ||
| KRYS | KRYSTAL BIOTECH INC | $339.06 | $92.44 | 266.79% | 43.75x | 43.70x | 23.80x | 7.83x | 2.10x | $237.38M | 2.39% | $1.28B | 43.59 | $9.50B | 44.42 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.55 | $16.85 | 277.11% | 64.85x | 49.78x | 6.45x | 8.07x | 1.76x | $164.23M | 3.38% | $605.69M | 7.92 | $4.71B | 42.23 | ||
| ADMA | ADMA BIOLOGICS INC | $8.59 | $8.95 | -4.05% | 12.45x | 10.24x | 3.98x | 5.10x | 0.52x | $107.90M | 5.32% | $390.33M | 1.65 | $2.05B | 9.26 | ||
| HALO | HALOZYME THERAPEUTICS INC | $78.60 | $69.38 | 13.29% | 26.55x | 9.46x | 6.16x | 42.45x | 0.47x | $667.65M | 7.19% | $219.64M | 1.86 | $11.16B | 17.88 | ||
| RPRX | ROYALTY PHARMA PLC | $58.42 | $39.51 | 47.85% | 30.59x | 10.89x | 10.46x | 3.39x | 0.64x | $2.34B | 9.17% | $9.94B | 22.75 | $42.01B | 36.11 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.21 | $38.10 | 55.39% | 42.29x | 16.03x | 3.52x | 1.84x | 0.63x | $767.06M | 6.73% | $6.21B | 32.27 | $9.80B | 20.32 | ||
| VCEL | VERICEL CORP | $46.14 | $8.89 | 419.08% | 107.30x | 95.71x | 8.02x | 6.61x | 2.26x | $47.49M | 2.03% | $356.23M | 7.02 | $2.34B | 57.93 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $254.22 | $47.90 | 430.76% | 540.89x | 9.82x | 3.55x | 3.52x | 1.83x | $1.30B | 8.25% | $4.53B | 73.22 | $19.51B | 28.90 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $305.47 | $95.70 | 219.19% | 38.67x | 33.36x | 22.13x | 6.14x | 1.81x | $122.22M | 2.01% | $997.32M | 50.16 | $6.46B | 28.64 | ||
| ASND | ASCENDIS PHARMA A | $255.20 | $78.17 | 226.46% | 27.05x | 17.54x | 15.56x | 27.61x | 2.80x | $52.94M | 0.33% | $574.09M | 9.24 | $16.23B | 174.06 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.84 | $34.71 | 6.14% | 14.56x | 9.79x | 2.37x | 2.34x | 0.55x | $341.79M | 16.05% | $910.35M | 15.75 | $1.70B | 7.18 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.38 | $8.74 | -84.20% | 5.11x | -4.67x | 1.29x | 1.51x | 0.06x | $7.24M | 9.13% | $52.93M | 0.92 | $26.25M | 1.69 | ||
| TECH | BIO-TECHNE CORP | $71.63 | $16.30 | 339.56% | 100.89x | 34.33x | 9.25x | 5.38x | 1.85x | $269.60M | 2.41% | $2.09B | 13.34 | $11.30B | 44.13 | ||
| TGTX | TG THERAPEUTICS INC | $53.95 | $21.20 | 154.53% | 16.75x | 38.22x | 11.13x | 14.16x | 3.76x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.57B | 57.11 | ||
| EXEL | EXELIXIS INC | $56.12 | $30.25 | 85.51% | 17.99x | 17.22x | 6.10x | 7.29x | 1.29x | $917.69M | 6.33% | $1.94B | 7.49 | $14.05B | 13.30 | ||
| UTHR | UNITED THERAPEUTICS CORP | $535.83 | $233.52 | 129.45% | 18.30x | 19.63x | 7.35x | 3.85x | 2.10x | $1.02B | 4.36% | $5.90B | 135.66 | $21.46B | 12.53 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $482.00 | $162.29 | 197.00% | 28.34x | 24.93x | 10.02x | 6.32x | 2.10x | $3.71B | 3.03% | $19.36B | 76.20 | $118.83B | 22.03 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.49 | $2.07 | 68.81% | 14.54x | 14.98x | 2.14x | 3.38x | 1.36x | $4.11M | 1.46% | $82.33M | 1.03 | $213.99M | 10.07 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $675.19 | $422.63 | 59.76% | 15.86x | 14.44x | 4.71x | 2.25x | 1.08x | $4.11B | 5.86% | $31.42B | 302.15 | $70.53B | 12.28 | ||
| VCYT | VERACYTE INC | $59.53 | $8.77 | 578.66% | 53.63x | 53.68x | 8.74x | 3.53x | 6.32x | $155.34M | 3.28% | $1.34B | 16.90 | $4.52B | 39.33 | ||
| INCY | INCYTE CORP | $117.39 | $64.15 | 82.98% | 16.10x | 14.73x | 4.37x | 4.17x | 1.43x | $1.45B | 6.20% | $5.62B | 28.21 | $20.02B | 10.70 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.